Midatech Pharma US, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients
Phase 4
Terminated
- Conditions
- Oral Mucositis
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Midatech Pharma US Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT03490396
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States
News
No news found